{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:15:46Z","timestamp":1788959746396,"version":"build-2803163510"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12602-025-10632-0","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:07:28Z","timestamp":1750997248000},"page":"2818-2837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-1414","authenticated-orcid":false,"given":"Mandeep Kumar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-4065","authenticated-orcid":false,"given":"Kanupriya","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-088X","authenticated-orcid":false,"given":"Snigdha","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-9858","authenticated-orcid":false,"given":"Rajnish","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"10632_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/J.ARR.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357. https:\/\/doi.org\/10.1016\/J.ARR.2024.102357","journal-title":"Ageing Res Rev"},{"key":"10632_CR2","doi-asserted-by":"crossref","unstructured":"Li KR, Wu AG, Tang Y et al (2022) The key role of magnetic resonance imaging in the detection of neurodegenerative diseases-associated biomarkers: a review. Mol Neurobiol 59(10):5935-54","DOI":"10.1007\/s12035-022-02944-x"},{"key":"10632_CR3","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1097\/ms9.0000000000001142","volume":"85","author":"P Prajjwal","year":"2023","unstructured":"Prajjwal P, Flores Sanga HS, Acharya K et al (2023) Parkinson\u2019s disease updates: addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Ann Med Surg 85:4887. https:\/\/doi.org\/10.1097\/ms9.0000000000001142","journal-title":"Ann Med Surg"},{"key":"10632_CR4","doi-asserted-by":"crossref","unstructured":"Sarkar SK, Willson AML, Jordan MA (2024) The plasticity of immune cell response complicates dissecting the underlying pathology of multiple sclerosis. J Immunol Res 2024(1):5383099","DOI":"10.1155\/2024\/5383099"},{"key":"10632_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.952161","volume":"10","author":"C Ding","year":"2022","unstructured":"Ding C, Wu Y, Chen X et al (2022) Global, regional, and national burden and attributable risk factors of neurological disorders: the global burden of disease study 1990\u20132019. Front Public Health 10:952161. https:\/\/doi.org\/10.3389\/fpubh.2022.952161","journal-title":"Front Public Health"},{"key":"10632_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100257","volume":"17","author":"A Naheed","year":"2023","unstructured":"Naheed A, Hakim M, Islam MS et al (2023) Prevalence of dementia among older age people and variation across different sociodemographic characteristics: a cross-sectional study in Bangladesh. The Lancet Regional Health - Southeast Asia 17:100257. https:\/\/doi.org\/10.1016\/j.lansea.2023.100257","journal-title":"The Lancet Regional Health - Southeast Asia"},{"key":"10632_CR7","doi-asserted-by":"publisher","unstructured":"Ou Z, Pan J, Tang S et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","DOI":"10.3389\/fpubh.2021.776847"},{"key":"10632_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Nichols E et al (2019) Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:269. https:\/\/doi.org\/10.1016\/S1474-4422(18)30443-5","journal-title":"Lancet Neurol"},{"key":"10632_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur KC, Calvo A, Price TR et al (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 7:12408. https:\/\/doi.org\/10.1038\/ncomms12408","journal-title":"Nat Commun"},{"key":"10632_CR10","doi-asserted-by":"publisher","unstructured":"Kim HS, Lyoo CH, Lee PH et al (2015) Current status of Huntington\u2019s disease in Korea: a nationwide survey and national registry analysis. J Mov Disord 8. https:\/\/doi.org\/10.14802\/jmd.14038","DOI":"10.14802\/jmd.14038"},{"issue":"11","key":"10632_CR11","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3390\/pharmaceutics15112599","volume":"15","author":"SK Niazi","year":"2023","unstructured":"Niazi SK (2023) Non-invasive drug delivery across the blood\u2013brain barrier: a prospective analysis. Pharmaceutics 15(11):2599","journal-title":"Pharmaceutics"},{"key":"10632_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121050","volume":"607","author":"D Gadhave","year":"2021","unstructured":"Gadhave D, Tupe S, Tagalpallewar A et al (2021) Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: in vitro and in vivo pharmacological studies. Int J Pharm 607:121050. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121050","journal-title":"Int J Pharm"},{"key":"10632_CR13","doi-asserted-by":"crossref","unstructured":"Aburto MR, Cryan JF (2024) Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota\u2013gut\u2013brain axis. Nat Rev Gastroenterol Hepatol 21(4):222-47","DOI":"10.1038\/s41575-023-00890-0"},{"key":"10632_CR14","doi-asserted-by":"publisher","unstructured":"Raj K, Arora N, Rohit, Awasthi A, Patel M, Chaudhary A, Singh S, Gupta GD (2024) Role of gut microbiota in neuroinflammation and neurological disorders. Frontiers in Clinical Drug Research - CNS and Neurological Disorders 12:80. https:\/\/doi.org\/10.2174\/9789815179842124120005","DOI":"10.2174\/9789815179842124120005"},{"key":"10632_CR15","doi-asserted-by":"crossref","unstructured":"Gracie DJ, Hamlin PJ, Ford AC (2019) The influence of the brain\u2013gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol 4(8):632-42","DOI":"10.1016\/S2468-1253(19)30089-5"},{"key":"10632_CR16","doi-asserted-by":"publisher","unstructured":"Bourebaba Y, Marycz K, Mularczyk M, Bourebaba L (2022) Postbiotics as potential new therapeutic agents for metabolic disorders management. Biomedicine and Pharmacotherapy 153:113138. https:\/\/doi.org\/10.1016\/j.biopha.2022.113138","DOI":"10.1016\/j.biopha.2022.113138"},{"key":"10632_CR17","doi-asserted-by":"publisher","unstructured":"Rafique N, Jan SY, Dar AH et al (2023) Promising bioactivities of postbiotics: a comprehensive review. J Agric Food Res 14. https:\/\/doi.org\/10.1016\/j.jafr.2023.100708","DOI":"10.1016\/j.jafr.2023.100708"},{"issue":"2","key":"10632_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s43393-023-00208-w","volume":"4","author":"K Prajapati","year":"2024","unstructured":"Prajapati K, Bisani K, Prajapati H et al (2024) Advances in probiotics research: mechanisms of action, health benefits, and limitations in applications. Systems Microbiology and Biomanufacturing 4(2):386\u2013406","journal-title":"Systems Microbiology and Biomanufacturing"},{"key":"10632_CR19","doi-asserted-by":"publisher","unstructured":"El-Enshasy HA, Yang S-T (2021) Probiotics, the natural microbiota in living organisms. CRC Pess. https:\/\/doi.org\/10.1201\/9781351027540","DOI":"10.1201\/9781351027540"},{"key":"10632_CR20","doi-asserted-by":"publisher","unstructured":"Anad\u00f3n A, Ares I, Mart\u00ednez-Larra\u00f1aga MR, Mart\u00ednez MA (2021) Probiotics: safety and toxicity considerations. Nutraceuticals, 2nd edn. Academic Press pp 1081\u20131105. https:\/\/doi.org\/10.1016\/B978-0-12-821038-3.00065-3","DOI":"10.1016\/B978-0-12-821038-3.00065-3"},{"key":"10632_CR21","doi-asserted-by":"publisher","unstructured":"Amoah K, Dong X hui, Tan B ping et al (2021) Effects of three probiotic strains (Bacillus coagulans, B. licheniformis and Paenibacillus polymyxa) on growth, immune response, gut morphology and microbiota, and resistance against Vibrio harveyi of northern whitings, Sillago sihama Forssk\u00e1l (1775). Anim Feed Sci Technol 277. https:\/\/doi.org\/10.1016\/j.anifeedsci.2021.114958","DOI":"10.1016\/j.anifeedsci.2021.114958"},{"key":"10632_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10122431","volume":"10","author":"MG Lee","year":"2022","unstructured":"Lee MG, Joeng H, Shin J et al (2022) Potential probiotic properties of exopolysaccharide-producing Lacticaseibacillus paracasei EPS DA-BACS and prebiotic activity of its exopolysaccharide. Microorganisms 10:2431. https:\/\/doi.org\/10.3390\/microorganisms10122431","journal-title":"Microorganisms"},{"key":"10632_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.COFS.2019.12.003","volume":"32","author":"CP Barros","year":"2020","unstructured":"Barros CP, Guimar\u00e3es JT, Esmerino EA et al (2020) Paraprobiotics and postbiotics: concepts and potential applications in dairy products. Curr Opin Food Sci 32:1\u20138. https:\/\/doi.org\/10.1016\/J.COFS.2019.12.003","journal-title":"Curr Opin Food Sci"},{"key":"10632_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.ALCOHOL.2018.03.005","volume":"74","author":"S Leclercq","year":"2019","unstructured":"Leclercq S, St\u00e4rkel P, Delzenne NM, de Timary P (2019) The gut microbiota: a new target in the management of alcohol dependence? Alcohol 74:105\u2013111. https:\/\/doi.org\/10.1016\/J.ALCOHOL.2018.03.005","journal-title":"Alcohol"},{"key":"10632_CR25","doi-asserted-by":"publisher","first-page":"11245","DOI":"10.3390\/IJMS231911245","volume":"23","author":"A G\u00f3ralczyk-Bi\u0144kowska","year":"2022","unstructured":"G\u00f3ralczyk-Bi\u0144kowska A, Szmajda-Krygier D, Koz\u0142owska E (2022) The microbiota\u2013gut\u2013brain axis in psychiatric disorders. Int J Mol Sci 23:11245\u201311245. https:\/\/doi.org\/10.3390\/IJMS231911245","journal-title":"Int J Mol Sci"},{"key":"10632_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2220\/biomedres.41.199","volume":"41","author":"A Kuwahara","year":"2020","unstructured":"Kuwahara A, Matsuda K, Kuwahara Y et al (2020) Microbiota-gut-brain axis: enteroendocrine cells and the enteric nervous system form an interface between the microbiota and the central nervous system. Biomed Res 41:199\u2013216. https:\/\/doi.org\/10.2220\/biomedres.41.199","journal-title":"Biomed Res"},{"key":"10632_CR27","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28:203\u2013209","journal-title":"Ann Gastroenterol"},{"key":"10632_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/pathophysiology31020019","volume":"31","author":"B Aljeradat","year":"2024","unstructured":"Aljeradat B, Kumar D, Abdulmuizz S et al (2024) Neuromodulation and the gut\u2013brain axis: therapeutic mechanisms and implications for gastrointestinal and neurological disorders. Pathophysiology 31:244\u2013268. https:\/\/doi.org\/10.3390\/pathophysiology31020019","journal-title":"Pathophysiology"},{"key":"10632_CR29","doi-asserted-by":"crossref","unstructured":"Sharma R, Gupta D, Mehrotra R, Mago P (2021) Psychobiotics: the next-generation probiotics for the brain. Curr Microbiol 78:449-463","DOI":"10.1007\/s00284-020-02289-5"},{"key":"10632_CR30","doi-asserted-by":"crossref","unstructured":"Annahazi A, Schemann M (2020) The enteric nervous system: \u201ca little brain in the gut.\u201d Neuroforum 26(1):31-42","DOI":"10.1515\/nf-2019-0027"},{"key":"10632_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/B978-0-323-99971-7.00004-7","volume":"95\u2013116","author":"M Green","year":"2024","unstructured":"Green M, Ratcliffe EM (2024) Influence of the microbiota on the development and function of the \u201csecond brain\u201d\u2014the enteric nervous system. The Gut-Brain Axis, Second Edition 95\u2013116:95. https:\/\/doi.org\/10.1016\/B978-0-323-99971-7.00004-7","journal-title":"The Gut-Brain Axis, Second Edition"},{"key":"10632_CR32","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/1567201816666190828153017","volume":"16","author":"NI Mansor","year":"2019","unstructured":"Mansor NI, Nordin N, Mohamed F et al (2019) Crossing the blood-brain barrier: a review on drug delivery strategies for treatment of the central nervous system diseases. Curr Drug Deliv 16:698. https:\/\/doi.org\/10.2174\/1567201816666190828153017","journal-title":"Curr Drug Deliv"},{"key":"10632_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0118715249271548231115071021","volume":"24","author":"S Gupta","year":"2024","unstructured":"Gupta S, Dinesh S, Sharma S (2024) Bridging the mind and gut: uncovering the intricacies of neurotransmitters, neuropeptides, and their influence on neuropsychiatric disorders. Cent Nerv Syst Agents Med Chem 24:2. https:\/\/doi.org\/10.2174\/0118715249271548231115071021","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10632_CR34","doi-asserted-by":"crossref","unstructured":"Comess JE, Abad-Jorge A (2023) Introduction to the gut microbiome and its impact on health and disease. Top Clin Nutr 38(3):183-95","DOI":"10.1097\/TIN.0000000000000324"},{"key":"10632_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2020.105314","volume":"164","author":"T Doifode","year":"2021","unstructured":"Doifode T, Giridharan VV, Generoso JS et al (2021) The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology. Pharmacol Res 164:105314. https:\/\/doi.org\/10.1016\/J.PHRS.2020.105314","journal-title":"Pharmacol Res"},{"key":"10632_CR36","doi-asserted-by":"crossref","unstructured":"Toor D, Wasson MK, Kumar P et al (2019) Dysbiosis disrupts gut immune homeostasis and promotes gastric diseases. Int J Mol Sci 20(10):2432","DOI":"10.3390\/ijms20102432"},{"key":"10632_CR37","doi-asserted-by":"crossref","unstructured":"Afzaal M, Saeed F, Shah YA, et al (2022) Human gut microbiota in health and disease: unveiling the relationship. Front Microbiol 13:999001","DOI":"10.3389\/fmicb.2022.999001"},{"key":"10632_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/NN.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, De Angelis ALH, Jaitin D et al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18:965\u2013977. https:\/\/doi.org\/10.1038\/NN.4030","journal-title":"Nat Neurosci"},{"key":"10632_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/J.CELL.2016.10.020","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, Smeekens SP, Vlamakis H et al (2016) Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167:1125-1136.e8. https:\/\/doi.org\/10.1016\/J.CELL.2016.10.020","journal-title":"Cell"},{"key":"10632_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15062","volume":"8","author":"S Leclercq","year":"2017","unstructured":"Leclercq S, Mian FM, Stanisz AM et al (2017) Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat Commun 8:15062. https:\/\/doi.org\/10.1038\/ncomms15062","journal-title":"Nat Commun"},{"key":"10632_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/J.REDOX.2018.01.008","volume":"15","author":"JN Cobley","year":"2018","unstructured":"Cobley JN, Fiorello ML, Bailey DM (2018) 13 reasons why the brain is susceptible to oxidative stress. Redox Biol 15:490\u2013503. https:\/\/doi.org\/10.1016\/J.REDOX.2018.01.008","journal-title":"Redox Biol"},{"key":"10632_CR42","doi-asserted-by":"crossref","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24(8):1583","DOI":"10.3390\/molecules24081583"},{"key":"10632_CR43","doi-asserted-by":"publisher","first-page":"1158198","DOI":"10.3389\/FCHEM.2023.1158198\/BIBTEX","volume":"11","author":"P Chaudhary","year":"2023","unstructured":"Chaudhary P, Janmeda P, Docea AO et al (2023) Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. Front Chem 11:1158198. https:\/\/doi.org\/10.3389\/FCHEM.2023.1158198\/BIBTEX","journal-title":"Front Chem"},{"key":"10632_CR44","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1016\/J.APSB.2023.07.010","volume":"13","author":"J Feng","year":"2023","unstructured":"Feng J, Zheng Y, Guo M et al (2023) Oxidative stress, the blood\u2013brain barrier and neurodegenerative diseases: the critical beneficial role of dietary antioxidants. Acta Pharm Sin B 13:3988\u20134024. https:\/\/doi.org\/10.1016\/J.APSB.2023.07.010","journal-title":"Acta Pharm Sin B"},{"key":"10632_CR45","doi-asserted-by":"publisher","unstructured":"Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, Yamamoto M (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28(8):2758\u20132770. https:\/\/doi.org\/10.1128\/MCB.01704-07","DOI":"10.1128\/MCB.01704-07"},{"key":"10632_CR46","doi-asserted-by":"publisher","unstructured":"Berm\u00fadez-Humar\u00e1n, LG, Salinas E, Ortiz GG, Ramirez-Jirano, LJ, Morales JA, Bitzer Quintero OK (2019) From probiotics to psychobiotics: live beneficial bacteria which act on the brain-gut axis. Nutrients 11(4):890. https:\/\/doi.org\/10.3390\/nu11040890","DOI":"10.3390\/nu11040890"},{"key":"10632_CR47","doi-asserted-by":"publisher","unstructured":"Tankou S, Regev K, Healy B et al (2018) A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann neurol.https:\/\/doi.org\/10.1002\/ana.25244","DOI":"10.1002\/ana.25244"},{"key":"10632_CR48","doi-asserted-by":"publisher","unstructured":"Agahi A, Hamidi GA, Daneshvar R et al (2018) Does severity of Alzheimer\u2019s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front Neurol 9. https:\/\/doi.org\/10.3389\/fneur.2018.00662","DOI":"10.3389\/fneur.2018.00662"},{"key":"10632_CR49","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1389200219666180813144834","volume":"15","author":"F Leblhuber","year":"2018","unstructured":"Leblhuber F, Steiner K, Schuetz B et al (2018) Probiotic supplementation in patients with Alzheimer\u2019s dementia - an explorative intervention study. Curr Alzheimer Res 15:1106. https:\/\/doi.org\/10.2174\/1389200219666180813144834","journal-title":"Curr Alzheimer Res"},{"key":"10632_CR50","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1007\/s12035-018-0973-4","volume":"55","author":"L Bonfili","year":"2018","unstructured":"Bonfili L, Cecarini V, Cuccioloni M et al (2018) SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol Neurobiol 55:7987. https:\/\/doi.org\/10.1007\/s12035-018-0973-4","journal-title":"Mol Neurobiol"},{"key":"10632_CR51","doi-asserted-by":"publisher","unstructured":"Azm SAN, Djazayeri A, Safa M et al (2017) Probiotics improve insulin resistance status in an experimental model of Alzheimer\u2019s disease. Med J Islam Repub Iran 31. https:\/\/doi.org\/10.14196\/MJIRI.31.103","DOI":"10.14196\/MJIRI.31.103"},{"key":"10632_CR52","doi-asserted-by":"publisher","unstructured":"Nimgampalle M, Yellamma K (2017) Anti-Alzheimer properties of probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer\u2019s disease induced albino rats. J Clin Diag Res 11. https:\/\/doi.org\/10.7860\/JCDR\/2017\/26106.10428","DOI":"10.7860\/JCDR\/2017\/26106.10428"},{"key":"10632_CR53","doi-asserted-by":"publisher","unstructured":"Akbari E, Asemi Z, Kakhaki RD et al (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8. https:\/\/doi.org\/10.3389\/fnagi.2016.00256","DOI":"10.3389\/fnagi.2016.00256"},{"key":"10632_CR54","doi-asserted-by":"crossref","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600-11","DOI":"10.1002\/mds.26431"},{"key":"10632_CR55","doi-asserted-by":"publisher","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R et al (2019) Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition 38. https:\/\/doi.org\/10.1016\/j.clnu.2018.05.018","DOI":"10.1016\/j.clnu.2018.05.018"},{"key":"10632_CR56","unstructured":"Borzabadi S, Oryan S, Eidi A et al. (2018) The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Arch Iran Med 21(7):289-295"},{"key":"10632_CR57","doi-asserted-by":"publisher","unstructured":"Barichella M, Pacchetti C, Bolliri C et al (2016) Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87. https:\/\/doi.org\/10.1212\/WNL.0000000000003127","DOI":"10.1212\/WNL.0000000000003127"},{"key":"10632_CR58","doi-asserted-by":"publisher","unstructured":"Georgescu D, Ancusa OE, Georgescu LA et al (2016) Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: is there hope? Clin Interv Aging 11. https:\/\/doi.org\/10.2147\/CIA.S106284","DOI":"10.2147\/CIA.S106284"},{"key":"10632_CR59","unstructured":"Cassani E, Privitera G, Pezzoli G, et al (2011) Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol Dietol 57(2):117-121"},{"key":"10632_CR60","doi-asserted-by":"publisher","unstructured":"Lu CS, Chang HC, Weng YH, et al (2021) The add-on effect of Lactobacillus plantarum PS128 in patients with Parkinson\u2019s disease: a pilot study. Front Nutr 8. https:\/\/doi.org\/10.3389\/fnut.2021.650053","DOI":"10.3389\/fnut.2021.650053"},{"issue":"5","key":"10632_CR61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","volume":"62","author":"JM Taylor","year":"2013","unstructured":"Taylor JM, Main BS, Crack PJ (2013) Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease. Neurochem Int 62(5):803\u2013819","journal-title":"Neurochem Int"},{"key":"10632_CR62","doi-asserted-by":"publisher","unstructured":"Tan AH, Lim SY, Chong KK, A Manap MAA, Hor JW, Lim JL, Low SC, Chong CW, Mahadeva S, Lang AE (2021) Probiotics for constipation in parkinson disease: a randomized placebo-controlled study. Neurology 96(5):e772\u2013e782. https:\/\/doi.org\/10.1212\/WNL.0000000000010998","DOI":"10.1212\/WNL.0000000000010998"},{"key":"10632_CR63","doi-asserted-by":"crossref","unstructured":"Liddle RA (2018) Parkinson\u2019s disease from the gut. Brain Res 1693:201-206","DOI":"10.1016\/j.brainres.2018.01.010"},{"key":"10632_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2024.01.024","volume":"18","author":"TS Dong","year":"2024","unstructured":"Dong TS, Mayer E (2024) Advances in brain\u2013gut\u2013microbiome interactions: a comprehensive update on signaling mechanisms, disorders, and therapeutic implications. Cell Mol Gastroenterol Hepatol 18:1\u201313. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.01.024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10632_CR65","doi-asserted-by":"publisher","unstructured":"Mitrea L, Neme\u015f S-A, Szabo K et al (2022) Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front Med (Lausanne) 9. https:\/\/doi.org\/10.3389\/fmed.2022.813204","DOI":"10.3389\/fmed.2022.813204"},{"key":"10632_CR66","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jtcme.2024.03.011","volume":"14","author":"S Ferrari","year":"2024","unstructured":"Ferrari S, Mul\u00e8 S, Parini F et al (2024) The influence of the gut-brain axis on anxiety and depression: a review of the literature on the use of probiotics. J Tradit Complement Med 14:237\u2013255. https:\/\/doi.org\/10.1016\/j.jtcme.2024.03.011","journal-title":"J Tradit Complement Med"},{"key":"10632_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191711022","volume":"19","author":"D Zieli\u0144ska","year":"2022","unstructured":"Zieli\u0144ska D, Karbowiak M, Brzezicka A (2022) The role of psychobiotics to ensure mental health during the COVID-19 pandemic\u2014a current state of knowledge. Int J Environ Res Public Health 19:11022. https:\/\/doi.org\/10.3390\/ijerph191711022","journal-title":"Int J Environ Res Public Health"},{"key":"10632_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114816","volume":"163","author":"S Aghamohammad","year":"2023","unstructured":"Aghamohammad S, Hafezi A, Rohani M (2023) Probiotics as functional foods: how probiotics can alleviate the symptoms of neurological disabilities. Biomed Pharmacother 163:114816. https:\/\/doi.org\/10.1016\/j.biopha.2023.114816","journal-title":"Biomed Pharmacother"},{"key":"10632_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu16071054","volume":"16","author":"A Dziedzic","year":"2024","unstructured":"Dziedzic A, Maciak K, Bli\u017aniewska-Kowalska K et al (2024) The power of psychobiotics in depression: a modern approach through the microbiota\u2013gut\u2013brain axis: a literature review. Nutrients 16:1054. https:\/\/doi.org\/10.3390\/nu16071054","journal-title":"Nutrients"},{"key":"10632_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu13062099","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y (2021) Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients 13:2099. https:\/\/doi.org\/10.3390\/nu13062099","journal-title":"Nutrients"},{"key":"10632_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34092","volume":"10","author":"S Ashique","year":"2024","unstructured":"Ashique S, Mohanto S, Ahmed MG et al (2024) Gut-brain axis: a cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 10:e34092. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34092","journal-title":"Heliyon"},{"key":"10632_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00469","volume":"21","author":"M Kaul","year":"2024","unstructured":"Kaul M, Mukherjee D, Weiner HL, Cox LM (2024) Gut microbiota immune cross-talk in amyotrophic lateral sclerosis. Neurotherapeutics 21:e00469. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00469","journal-title":"Neurotherapeutics"},{"key":"10632_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00441","volume":"21","author":"J Sun","year":"2024","unstructured":"Sun J, Zhang Y (2024) Microbiome and micronutrient in ALS: from novel mechanisms to new treatments. Neurotherapeutics 21:e00441. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00441","journal-title":"Neurotherapeutics"},{"key":"10632_CR74","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1134\/S0362119718080029","volume":"44","author":"IS Bakulin","year":"2018","unstructured":"Bakulin IS, Chervyakov AV, Kremneva EI et al (2018) Structural and functional neuroimaging in amyotrophic lateral sclerosis. Hum Physiol 44:844\u2013854. https:\/\/doi.org\/10.1134\/S0362119718080029","journal-title":"Hum Physiol"},{"key":"10632_CR75","doi-asserted-by":"publisher","unstructured":"Fukuyama Y, Kubo M, Harada K (2024) Neurotrophic natural products. Progress in the chemistry of organic natural products 123:1\u2013473. https:\/\/doi.org\/10.1007\/978-3-031-42422-9_1","DOI":"10.1007\/978-3-031-42422-9_1"},{"key":"10632_CR76","doi-asserted-by":"crossref","unstructured":"Wu H, Denna TH, Storkersen JN, Gerriets VA (2019) Beyond a neurotransmitter: the role of serotonin in inflammation and immunity. Pharmacol Res 140:100-14","DOI":"10.1016\/j.phrs.2018.06.015"},{"key":"10632_CR77","doi-asserted-by":"publisher","first-page":"G1288","DOI":"10.1152\/ajpgi.00341.2012","volume":"303","author":"Y Asano","year":"2012","unstructured":"Asano Y, Hiramoto T, Nishino R et al (2012) Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303:G1288. https:\/\/doi.org\/10.1152\/ajpgi.00341.2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10632_CR78","doi-asserted-by":"publisher","unstructured":"Valenzuela JA, Fl\u00f3rez AB, V\u00e1zquez L et al (2019) Production of \u03b3-aminobutyric acid (GABA) by lactic acid bacteria strains isolated from traditional, starter-free dairy products made of raw milk. Benef Microbes 10. https:\/\/doi.org\/10.3920\/BM2018.0176","DOI":"10.3920\/BM2018.0176"},{"key":"10632_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212856","volume":"14","author":"M Bistoletti","year":"2019","unstructured":"Bistoletti M, Caputi V, Baranzini N et al (2019) Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice. PLoS One 14:e0212856. https:\/\/doi.org\/10.1371\/journal.pone.0212856","journal-title":"PLoS One"},{"key":"10632_CR80","doi-asserted-by":"crossref","unstructured":"Ji J, Jin W, Liu SJ et al (2023) Probiotics, prebiotics, and postbiotics in health and disease. MedComm (Beijing) 4(6):e420","DOI":"10.1002\/mco2.420"},{"issue":"8","key":"10632_CR81","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME et al (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491\u2013502","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10632_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13010074","volume":"13","author":"M Quansah","year":"2025","unstructured":"Quansah M, David MA, Martins R et al (2025) The beneficial effects of Lactobacillus strains on gut microbiome in Alzheimer\u2019s disease: a systematic review. Healthcare 13:74. https:\/\/doi.org\/10.3390\/healthcare13010074","journal-title":"Healthcare"},{"key":"10632_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00374","volume":"10","author":"I Varela-Nieto","year":"2018","unstructured":"Varela-Nieto I, Chowen JA, Garc\u00eda-Segura LM (2018) Editorial: hormones and neural aging: lessons from experimental models. Front Aging Neurosci 10:374. https:\/\/doi.org\/10.3389\/fnagi.2018.00374","journal-title":"Front Aging Neurosci"},{"key":"10632_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2019.00020","volume":"11","author":"SD Glasgow","year":"2019","unstructured":"Glasgow SD, McPhedrain R, Madranges JF et al (2019) Approaches and limitations in the investigation of synaptic transmission and plasticity. Front Synaptic Neurosci 11:20. https:\/\/doi.org\/10.3389\/fnsyn.2019.00020","journal-title":"Front Synaptic Neurosci"},{"key":"10632_CR85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbr.2015.02.044","volume":"287","author":"HM Savignac","year":"2015","unstructured":"Savignac HM, Tramullas M, Kiely B et al (2015) Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res 287:59\u201372. https:\/\/doi.org\/10.1016\/j.bbr.2015.02.044","journal-title":"Behav Brain Res"},{"key":"10632_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051602","volume":"13","author":"G Zhu","year":"2021","unstructured":"Zhu G, Zhao J, Zhang H et al (2021) Administration of Bifidobacterium breve improves the brain function of A\u03b21-42-treated mice via the modulation of the gut microbiome. Nutrients 13:1602. https:\/\/doi.org\/10.3390\/nu13051602","journal-title":"Nutrients"},{"key":"10632_CR87","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.parkreldis.2019.06.022","volume":"65","author":"C-T Hong","year":"2019","unstructured":"Hong C-T, Chan L, Wu D et al (2019) Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 65:224\u2013229. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.022","journal-title":"Parkinsonism Relat Disord"},{"key":"10632_CR88","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.bbii.2023.100038","volume":"5","author":"N Gupta","year":"2024","unstructured":"Gupta N, Agarwal AK, Al-Dossari M, Abd EL-Gawaad NS (2024) Psychobiotic potential of Lactiplantibacillus plantarum: current perspective in neurodegeneration and geriatric therapies. Brain Behavior and Immunity Integrative 5:100038. https:\/\/doi.org\/10.1016\/j.bbii.2023.100038","journal-title":"Brain Behavior and Immunity Integrative"},{"key":"10632_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2025.173972","volume":"249","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Ahmed HH, Kareem RA et al (2025) Short-chain fatty acids in Huntington\u2019s disease: mechanisms of action and their therapeutic implications. Pharmacol Biochem Behav 249:173972. https:\/\/doi.org\/10.1016\/j.pbb.2025.173972","journal-title":"Pharmacol Biochem Behav"},{"key":"10632_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662807","volume":"12","author":"D Erturk-Hasdemir","year":"2021","unstructured":"Erturk-Hasdemir D, Ochoa-Rep\u00e1raz J, Kasper DL, Kasper LH (2021) Exploring the gut-brain axis for the control of CNS inflammatory demyelination: immunomodulation by Bacteroides fragilis\u2019 polysaccharide A. Front Immunol 12:662807. https:\/\/doi.org\/10.3389\/fimmu.2021.662807","journal-title":"Front Immunol"},{"key":"10632_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00385","volume":"10","author":"B He","year":"2019","unstructured":"He B, Hoang TK, Tian X et al (2019) Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Front Immunol 10:385. https:\/\/doi.org\/10.3389\/fimmu.2019.00385","journal-title":"Front Immunol"},{"key":"10632_CR92","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/SCIENCE.AAG2770","volume":"356","author":"N Koppel","year":"2017","unstructured":"Koppel N, Rekdal VM, Balskus EP (2017) Chemical transformation of xenobiotics by the human gut microbiota. Science 356:1246\u20131257. https:\/\/doi.org\/10.1126\/SCIENCE.AAG2770","journal-title":"Science"},{"key":"10632_CR93","doi-asserted-by":"publisher","unstructured":"Dziedzic A, Maciak K, Bli\u017aniewska-Kowalska K, Ga\u0142ecka M, Kobierecka W, Saluk J (2024) The power of psychobiotics in depression: a modern approach through the microbiota-gut-brain axis: a literature review. Nutrients 16(7):1054. https:\/\/doi.org\/10.3390\/nu16071054","DOI":"10.3390\/nu16071054"},{"key":"10632_CR94","doi-asserted-by":"publisher","unstructured":"Nishida K, Sawada D, Kawai T et al (2017) Para-psychobiotic Lactobacillus gasseri CP2305 ameliorates stress-related symptoms and sleep quality. J Appl Microbiol 123. https:\/\/doi.org\/10.1111\/jam.13594","DOI":"10.1111\/jam.13594"},{"key":"10632_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9102141","volume":"9","author":"JY Jung","year":"2021","unstructured":"Jung JY, Han SS, Kim ZH et al (2021) In-vitro characterization of growth inhibition against the gut pathogen of potentially probiotic lactic acid bacteria strains isolated from fermented products. Microorganisms 9:2141. https:\/\/doi.org\/10.3390\/microorganisms9102141","journal-title":"Microorganisms"},{"key":"10632_CR96","doi-asserted-by":"publisher","unstructured":"Zou R, Shen G, Wu Y, et al (2023) Akkermansia muciniphila plays a neuroprotective role in HMC3 cells through the \u2018gut-brain\u2019\u2019 axis.\u2019 Future Microbiol 18. https:\/\/doi.org\/10.2217\/fmb-2022-0007","DOI":"10.2217\/fmb-2022-0007"},{"key":"10632_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01166","volume":"8","author":"AM Patterson","year":"2017","unstructured":"Patterson AM, Mulder IE, Travis AJ et al (2017) Human gut symbiont Roseburia hominis promotes and regulates innate immunity. Front Immunol 8:1166. https:\/\/doi.org\/10.3389\/fimmu.2017.01166","journal-title":"Front Immunol"},{"key":"10632_CR98","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nut.2015.09.003","volume":"32","author":"G Akkasheh","year":"2016","unstructured":"Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M et al (2016) Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32:315. https:\/\/doi.org\/10.1016\/j.nut.2015.09.003","journal-title":"Nutrition"},{"key":"10632_CR99","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/WNF.0000000000000299","volume":"41","author":"T Miyaoka","year":"2018","unstructured":"Miyaoka T, Kanayama M, Wake R et al (2018) Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: a prospective open-label trial. Clin Neuropharmacol 41:151. https:\/\/doi.org\/10.1097\/WNF.0000000000000299","journal-title":"Clin Neuropharmacol"},{"key":"10632_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020305","volume":"11","author":"YH Hwang","year":"2019","unstructured":"Hwang YH, Park S, Paik JW et al (2019) Efficacy and safety of lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients 11:305. https:\/\/doi.org\/10.3390\/nu11020305","journal-title":"Nutrients"},{"key":"10632_CR101","doi-asserted-by":"publisher","unstructured":"Kato-Kataoka A, Nishida K, Takada M et al (2016) Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress. Benef Microbes 7. https:\/\/doi.org\/10.3920\/BM2015.0100","DOI":"10.3920\/BM2015.0100"},{"key":"10632_CR102","doi-asserted-by":"publisher","unstructured":"Kouchaki E, Tamtaji OR, Salami M et al (2017) Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr 36. https:\/\/doi.org\/10.1016\/j.clnu.2016.08.015","DOI":"10.1016\/j.clnu.2016.08.015"},{"key":"10632_CR103","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jff.2014.09.002","volume":"11","author":"J Nishihira","year":"2014","unstructured":"Nishihira J, Kagami-Katsuyama H, Tanaka A et al (2014) Elevation of natural killer cell activity and alleviation of mental stress by the consumption of yogurt containing Lactobacillus gasseri SBT2055 and Bifidobacterium longum SBT2928 in a double-blind, placebo-controlled clinical trial. J Funct Foods 11:261. https:\/\/doi.org\/10.1016\/j.jff.2014.09.002","journal-title":"J Funct Foods"},{"key":"10632_CR104","doi-asserted-by":"publisher","unstructured":"Mohammadi AA, Jazayeri S, Khosravi-Darani K et al (2016) The effects of probiotics on mental health and hypothalamic\u2013pituitary\u2013adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci 19. https:\/\/doi.org\/10.1179\/1476830515Y.0000000023","DOI":"10.1179\/1476830515Y.0000000023"},{"key":"10632_CR105","doi-asserted-by":"crossref","unstructured":"Kaviyarasan S, Chung Sia EL, Retinasamy T et al (2022) Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: a molecular crosstalk. Front Aging Neurosci 14:1015837","DOI":"10.3389\/fnagi.2022.1015837"},{"key":"10632_CR106","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/J.CGH.2018.01.018","volume":"17","author":"C de Simone","year":"2019","unstructured":"de Simone C (2019) The unregulated probiotic market. Clin Gastroenterol Hepatol 17:809\u2013817. https:\/\/doi.org\/10.1016\/J.CGH.2018.01.018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10632_CR107","doi-asserted-by":"crossref","unstructured":"Chidambaram SB, Essa MM, Rathipriya AG et al (2022) Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: tales of a vicious cycle. Pharmacol Ther 231:107988","DOI":"10.1016\/j.pharmthera.2021.107988"},{"key":"10632_CR108","doi-asserted-by":"crossref","unstructured":"Hirschberg S, Gisevius B, Duscha A, Haghikia A (2019) Implications of diet and the gut microbiome in neuroinflammatory and neurodegenerative diseases. Int J Mol Sci 20(12):3109","DOI":"10.3390\/ijms20123109"},{"key":"10632_CR109","doi-asserted-by":"crossref","unstructured":"Hasan N, Yang H (2019) Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 7:e7502","DOI":"10.7717\/peerj.7502"},{"key":"10632_CR110","doi-asserted-by":"publisher","unstructured":"Mansour SR, Moustafa MAA, Saad BM et al (2021) Impact of diet on human gut microbiome and disease risk. New Microbes New Infect 41. https:\/\/doi.org\/10.1016\/j.nmni.2021.100845","DOI":"10.1016\/j.nmni.2021.100845"},{"key":"10632_CR111","doi-asserted-by":"publisher","first-page":"644138","DOI":"10.3389\/fnut.2021.644138","volume":"8","author":"Q Su","year":"2021","unstructured":"Su Q, Liu Q (2021) Factors affecting gut microbiome in daily diet. Front Nutr 8:644138","journal-title":"Front Nutr"},{"key":"10632_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2019.110576","volume":"69","author":"N Saiyasit","year":"2020","unstructured":"Saiyasit N, Chunchai T, Prus D et al (2020) Gut dysbiosis develops before metabolic disturbance and cognitive decline in high-fat diet\u2013induced obese condition. Nutrition 69:110576. https:\/\/doi.org\/10.1016\/j.nut.2019.110576","journal-title":"Nutrition"},{"key":"10632_CR113","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3389\/fneur.2018.00701","volume":"9","author":"C Strafella","year":"2018","unstructured":"Strafella C, Caputo V, Galota MR et al (2018) Application of precision medicine in neurodegenerative diseases. Front Neurol 9:701","journal-title":"Front Neurol"},{"key":"10632_CR114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bpg.2023.101828","volume":"62-63","author":"E Rinninella","year":"2023","unstructured":"Rinninella E, Tohumcu E, Raoul P et al (2023) The role of diet in shaping human gut microbiota. Best Pract Res Clin Gastroenterol 62\u201363:62\u201363","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10632_CR115","doi-asserted-by":"crossref","unstructured":"Sasso JM, Ammar RM, Tenchov R et al (2023) Gut microbiome-brain alliance: a landscape view into mental and gastrointestinal health and disorders. ACS Chem Neurosci 14(10):1717-63","DOI":"10.1021\/acschemneuro.3c00127"},{"key":"10632_CR116","doi-asserted-by":"crossref","unstructured":"Thangaleela S, Sivamaruthi BS, Kesika P, Chaiyasut C (2022) Role of probiotics and diet in the management of neurological diseases and mood states: a review. Microorganisms 10(11):2268","DOI":"10.3390\/microorganisms10112268"},{"key":"10632_CR117","doi-asserted-by":"crossref","unstructured":"Bashir B, Alam S, Khandale N, et al (2024) Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Res Rev 95:102236","DOI":"10.1016\/j.arr.2024.102236"},{"key":"10632_CR118","doi-asserted-by":"crossref","unstructured":"Sarkar A, Lehto SM, Harty S et al (2016) Psychobiotics and the manipulation of bacteria\u2013gut\u2013brain signals. Trends Neurosci 39(11):763-81","DOI":"10.1016\/j.tins.2016.09.002"},{"key":"10632_CR119","doi-asserted-by":"crossref","unstructured":"Uceda S, Echeverry-Alzate V, Reiriz-Rojas M et al (2023) Gut microbial metabolome and dysbiosis in neurodegenerative diseases: psychobiotics and fecal microbiota transplantation as a therapeutic approach\u2014a comprehensive narrative review. Int J Mol Sci 24(17):13294","DOI":"10.3390\/ijms241713294"},{"key":"10632_CR120","doi-asserted-by":"publisher","unstructured":"Zhou P, Chen C, Patil S, Dong S (2024) Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony. Front Nutr 11:1355542.https:\/\/doi.org\/10.3389\/fnut.2024.1355542","DOI":"10.3389\/fnut.2024.1355542"},{"key":"10632_CR121","doi-asserted-by":"crossref","unstructured":"Lin PY, Chiu CC, Huang SY, Su KP (2012) A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry73(9):11741","DOI":"10.4088\/JCP.11r07546"},{"key":"10632_CR122","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/phrs.1999.0495","volume":"40","author":"LA Horrocks","year":"1999","unstructured":"Horrocks LA, Yeo YK (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40:211. https:\/\/doi.org\/10.1006\/phrs.1999.0495","journal-title":"Pharmacol Res"},{"key":"10632_CR123","doi-asserted-by":"crossref","unstructured":"McCann JC, Ames BN (2005) Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 82(2):281-95","DOI":"10.1093\/ajcn\/82.2.281"},{"key":"10632_CR124","doi-asserted-by":"publisher","unstructured":"Martinez-Lapiscina EH, Clavero P, Toledo E, et al (2013) Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 17. https:\/\/doi.org\/10.1007\/s12603-013-0027-6","DOI":"10.1007\/s12603-013-0027-6"},{"key":"10632_CR125","doi-asserted-by":"crossref","unstructured":"Theodore LE, Kellow NJ, Mcneil EA et al (2021) Nut consumption for cognitive performance: a systematic review. Adv Nutrit 12(3):777-792.","DOI":"10.1093\/advances\/nmaa153"},{"key":"10632_CR126","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1590\/s1516-31802012000600013","volume":"130","author":"E Sydenham","year":"2012","unstructured":"Sydenham E, Dangour AD, Lim WS (2012) Omega 3 fatty acid for the prevention of cognitive decline and dementia. Sao Paulo Medical Journal 130:419. https:\/\/doi.org\/10.1590\/s1516-31802012000600013","journal-title":"Sao Paulo Medical Journal"},{"key":"10632_CR127","doi-asserted-by":"publisher","unstructured":"Van Praag H, Lucero MJ, Yeo GW et al (2007) Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 27. https:\/\/doi.org\/10.1523\/JNEUROSCI.0914-07.2007","DOI":"10.1523\/JNEUROSCI.0914-07.2007"},{"key":"10632_CR128","doi-asserted-by":"publisher","unstructured":"Wu GD, Chen J, Hoffmann C et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science (1979) 334. https:\/\/doi.org\/10.1126\/science.1208344","DOI":"10.1126\/science.1208344"},{"key":"10632_CR129","doi-asserted-by":"publisher","unstructured":"Cordero K, Coronel GG, Serrano-Ill\u00e1n M et al. (2018) Effects of dietary vitamin E supplementation in bladder function and spasticity during spinal cord injury. Brain Sci 8. https:\/\/doi.org\/10.3390\/brainsci8030038","DOI":"10.3390\/brainsci8030038"},{"key":"10632_CR130","doi-asserted-by":"publisher","first-page":"R1392","DOI":"10.1152\/ajpregu.00834.2004","volume":"289","author":"A Navarro","year":"2005","unstructured":"Navarro A, G\u00f3mez C, S\u00e1nchez-Pino MJ et al (2005) Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am J Physiol Regul Integr Comp Physiol 289:R1392. https:\/\/doi.org\/10.1152\/ajpregu.00834.2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10632_CR131","doi-asserted-by":"crossref","unstructured":"Malar DS, Prasanth MI, Brimson JM et al (2020) Neuroprotective properties of green tea (Camellia sinensis) in Parkinson\u2019s disease: a review. Molecules 25(17):3926","DOI":"10.3390\/molecules25173926"},{"key":"10632_CR132","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11064-007-9403-0","volume":"33","author":"J Liu","year":"2008","unstructured":"Liu J (2008) The effects and mechanisms of mitochondrial nutrient \u03b1-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem Res 33:194\u2013203","journal-title":"Neurochem Res"},{"key":"10632_CR133","doi-asserted-by":"publisher","unstructured":"Ahire ED, Keservani RK, Balekundri A, Rajora AK,\u00a0Surana KR (2024) Effect of nutrients on brain function. Nutraceutical fruits and foods for neurodegenerative disorders. Academic Press pp 237\u2013248. https:\/\/doi.org\/10.1016\/B978-0-443-18951-7.00013-X","DOI":"10.1016\/B978-0-443-18951-7.00013-X"},{"key":"10632_CR134","doi-asserted-by":"publisher","unstructured":"Wang J, Ho L, Zhao W, et al (2008) Grape-derived polyphenolics prevent A\u03b2 oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer\u2019s disease. J Neurosci 28:. https:\/\/doi.org\/10.1523\/JNEUROSCI.0364-08.2008","DOI":"10.1523\/JNEUROSCI.0364-08.2008"},{"issue":"4","key":"10632_CR135","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.maturitas.2013.07.013","volume":"76","author":"E Agarwal","year":"2013","unstructured":"Agarwal E, Miller M, Yaxley A, Isenring E (2013) Malnutrition in the elderly: a narrative review. Maturitas 76(4):296\u2013302","journal-title":"Maturitas"},{"key":"10632_CR136","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52795","author":"CD Franco","year":"2024","unstructured":"Franco CD, Sagar RS, Bokhari SFH (2024) From microbes to memories: challenges and future perspectives regarding the gut-brain axis for improved cognitive health in Alzheimer\u2019s. Cureus. https:\/\/doi.org\/10.7759\/cureus.52795","journal-title":"Cureus"},{"key":"10632_CR137","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cmet.2024.03.004","volume":"36","author":"X Zhao","year":"2024","unstructured":"Zhao X, Liu S, Li S et al (2024) Unlocking the power of postbiotics: a revolutionary approach to nutrition for humans and animals. Cell Metab 36:725\u2013744. https:\/\/doi.org\/10.1016\/j.cmet.2024.03.004","journal-title":"Cell Metab"},{"key":"10632_CR138","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/S13311-014-0310-1\/TABLES\/6","volume":"12","author":"JM Cedarbaum","year":"2015","unstructured":"Cedarbaum JM, Stephenson D, Rudick R et al (2015) Commonalities and challenges in the development of clinical trial measures in neurology. Neurotherapeutics 12:151\u2013169. https:\/\/doi.org\/10.1007\/S13311-014-0310-1\/TABLES\/6","journal-title":"Neurotherapeutics"},{"key":"10632_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/NU12123896","volume":"12","author":"M Del Toro-Barbosa","year":"2020","unstructured":"Del Toro-Barbosa M, Hurtado-Romero A, Garcia-Amezquita LE, Garc\u00eda-Cayuela T (2020) Psychobiotics: mechanisms of action, evaluation methods and effectiveness in applications with food products. Nutrients 12:3896. https:\/\/doi.org\/10.3390\/NU12123896","journal-title":"Nutrients"},{"key":"10632_CR140","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/J.TIFS.2022.08.017","volume":"128","author":"KM Livingstone","year":"2022","unstructured":"Livingstone KM, Ramos-Lopez O, P\u00e9russe L et al (2022) Precision nutrition: a review of current approaches and future endeavors. Trends Food Sci Technol 128:253\u2013264. https:\/\/doi.org\/10.1016\/J.TIFS.2022.08.017","journal-title":"Trends Food Sci Technol"},{"key":"10632_CR141","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/S00394-020-02232-1","volume":"59","author":"JR Swann","year":"2020","unstructured":"Swann JR, Rajilic-Stojanovic M, Salonen A et al (2020) Considerations for the design and conduct of human gut microbiota intervention studies relating to foods. Eur J Nutr 59:3347. https:\/\/doi.org\/10.1007\/S00394-020-02232-1","journal-title":"Eur J Nutr"},{"key":"10632_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/MICROORGANISMS12030430","volume":"12","author":"ME Abouelela","year":"2024","unstructured":"Abouelela ME, Helmy YA (2024) Next-generation probiotics as novel therapeutics for improving human health: current trends and future perspectives. Microorganisms 12:430. https:\/\/doi.org\/10.3390\/MICROORGANISMS12030430","journal-title":"Microorganisms"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10632-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:59:09Z","timestamp":1774342749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10632-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10632"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10632-0","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"8 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}